A phase II study of daratumumab and pomalidomide in previously treated patients with AL amyloidosis OA10 (#466)
DOI:
10.26226/m.65f9bf8be6f73964e1d4f654
Publication Date:
2024-05-10T14:08:28Z
AUTHORS (14)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....